View Exam | PowerPak

1. Which one of the following United States populations had the highest number of new human immunodeficiency virus (HIV) infections in 2016?

A. People who inject drugs (PWID) B. Hispanic/Latino men who have sex with men (MSM) C. Black/African American MSM D. Black and Hispanic/Latina heterosexual women

2. Results of the START study suggest which of the following HIV-care–related opportunities for pharmacists?

A. Proactive HIV screening and identification of individuals at risk for HIV acquisition who may benefit from use of HIV preexposure prophylaxis (PrEP) B. Promotion of immediate initiation of antiretroviral therapy (ART) in early, asymptomatic HIV infection C. Pharmacy-consultation services regarding CD4-guided intermittent ART D. Monitoring for ART side effects, drug-drug interactions, and other variables affecting ART continuity

3. Which of the following accurately reflects Centers for Disease Control and Prevention (CDC) HIV-screening guidelines?

A. Oral rapid tests may be used for initial HIV screening when considering PrEP use B. Preliminary positive or inconclusive HIV antibody test results should prompt HIV-antibody retesting within 2 months C. 4th-generation combined HIV antibody/antigen tests do not detect HIV for at least 25 days following HIV infection D. 4th-generation combined antibody/antigen HIV testing must be used in conjunction with screening for symptoms of early (acute) HIV infection

4. Gillian, a 22-year-old female sex worker, requests information on HIV preexposure prophylaxis (PrEP). As you educate her on the benefits of PrEP for prevention of HIV acquisition, you will advise her that which one of the following ART regimens is currently FDA-approved for use as HIV PrEP?

A. Tenofovir alafenamide (TAF)/emtricitabine (FTC) B. TAF/FTC/rilpivirine C. Tenofovir disoproxil fumarate (TDF)/FTC D. Both TAF/FTC and TDF/FTC E. TDF/FTC/dolutegravir

5. Per CDC guidelines, both PrEP eligibility determination and 6-month–interval PrEP monitoring require documentation of which one of the following?

A. Negative pregnancy test B. Estimated creatinine clearance (eCrCl) ≥60 mL/min C. Negative hepatitis B virus (HBV) serology D. Repeat hepatitis C virus (HCV) serology

6. Joe, a 26-year-old MSM, has recently tested positive for HIV. He would like to be started on the same boosted protease inhibitor (PI)-based regimen that his HIV-positive partner has been prescribed. How do you counsel this patient regarding the March 2018 Department of Health and Human Services (DHHS) recommendations on first-line ART for most treatment-naïve individuals with HIV?

A. Boosted PI-based regimens should be used for initial therapy B. Integrase strand transfer inhibitor (INSTI)–based regimens should be used for initial therapy C. Boosted INSTIs, but not unboosted INSTIs, should be used for initial therapy D. Boosted PI- and INSTI-based regimens are equivalent choices for initial therapy

7. Monitoring ART effectiveness over the continuum of treatment includes which one of the following protocols?

A. CD4+ T lymphocyte (CD4+) count at entry; if ART initiation is deferred for any duration, repeat viral load (VL) and CD4+ count before initiating ART B. CD4+ count plus VL at entry and then only VL every 1 month until viral suppression C. CD4+ count within 2-4 weeks (≤8 weeks) after ART initiation and then every 4-8 weeks until VL is suppressed D. CD4+ count only at 4-8 weeks after ART-regimen modification (because of toxicity or regimen simplification) to confirm effectiveness

8. Key factors associated with polypharmacy and the prescribing of ≥5 medications among people living with HIV (PLWH) vs non-PLWH include which one of the following?

A. Comorbid type 2 diabetes B. Comorbid coronary heart disease C. Medicaid enrollment D. Older age

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which one of the following United States populations had the highest number of new human immunodeficiency virus (HIV) infections in 2016?

2. Results of the START study suggest which of the following HIV-care–related opportunities for pharmacists?

3. Which of the following accurately reflects Centers for Disease Control and Prevention (CDC) HIV-screening guidelines?

4. Gillian, a 22-year-old female sex worker, requests information on HIV preexposure prophylaxis (PrEP). As you educate her on the benefits of PrEP for prevention of HIV acquisition, you will advise her that which one of the following ART regimens is currently FDA-approved for use as HIV PrEP?

5. Per CDC guidelines, both PrEP eligibility determination and 6-month–interval PrEP monitoring require documentation of which one of the following?

7. Monitoring ART effectiveness over the continuum of treatment includes which one of the following protocols?

8. Key factors associated with polypharmacy and the prescribing of ≥5 medications among people living with HIV (PLWH) vs non-PLWH include which one of the following?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which one of the following United States populations had the highest number of new human immunodeficiency virus (HIV) infections in 2016?

2. Results of the START study suggest which of the following HIV-care–related opportunities for pharmacists?

3. Which of the following accurately reflects Centers for Disease Control and Prevention (CDC) HIV-screening guidelines?

4. Gillian, a 22-year-old female sex worker, requests information on HIV preexposure prophylaxis (PrEP). As you educate her on the benefits of PrEP for prevention of HIV acquisition, you will advise her that which one of the following ART regimens is currently FDA-approved for use as HIV PrEP?

5. Per CDC guidelines, both PrEP eligibility determination and 6-month–interval PrEP monitoring require documentation of which one of the following?

7. Monitoring ART effectiveness over the continuum of treatment includes which one of the following protocols?

8. Key factors associated with polypharmacy and the prescribing of ≥5 medications among people living with HIV (PLWH) vs non-PLWH include which one of the following?

« Return to Activity

Customers who Purchased
this Activity also Purchased